Female sterility is the inability to conceive due to problems related to the eggs that impede fertilization and, therefore, pregnancy. The alteration of the reproductive capacity can happen due to a variety of causes. The symptoms the woman experiences will be more or less noticeable depending on the cause.
For this reason, there may be situations in which the woman is not aware of her sterility until she undergoes the relevant fertility tests.
There are two main types of sterility:
Although they are two different types of infertility, the common point between them is the difficulty in achieving the desired pregnancy.
The different sections of this article have been assembled into the following table of contents.
Although the terms sterility and infertility are commonly used as synonyms, both by society in general and professionals in this field, it should be noted that their meaning is not exactly the same:
Be it as it may, both types hinder a woman's capacity to have a child, and therefore, are used interchangeably when talking about the causes, the signs, and the potential treatments to achieve a successful pregnancy.
Infertility problems in women can appear due to one or a combination of the following alterations:
A leading cause of female infertility is associated with the ovulation cycle. It is known as endocrine factor infertility because the menstrual cycle is regulated by a set of hormones such as GnRH (gonadotropin-releasing hormone), FSH (follicle-stimulating hormone), LH (luteinizing hormone), progesterone, and estradiol.
Variations in hormone levels can lead to:
In normal menstrual cycles, without endocrine alterations, ovulation takes place halfway through the menstrual cycle (on day 14 approximately), considering as day 1 the day when the menstrual period begins.
For this reason, the most fertile days are the closest to ovulation, that is, the moment when the egg is released by the ovary so that the sperm hopefully reaches and fertilizes it inside the Fallopian tube.
Should a woman present any of the above-listed problems related to ovulation, pregnancy is unlikely to be achieved even if she tried to conceive during her most fertile days.
It should be noted that a sudden alteration in a woman's menstrual cycle does not automatically translate into female sterility. A woman is considered to be sterile when the problem persists over time.
For more information on this topic, please visit the following link: Female infertility due to endocrine-ovarian factor.
The absence or the presence of alterations in the ovulation cycle leads to menstrual irregularities or even to amenorrhea (absence of menstrual periods). However, there are certain cases in which menstrual periods are apparently normal even though there are a series of problems related to hormones that hinder a woman's chances to become pregnant:
Some causes of the hormonal imbalances that affect the endocrine system's regulation of ovarian cycles are stress, obesity, anorexia, thyroid problems, certain medications, chemotherapy, radiotherapy, environmental factors and so on.
Assisted procreation, as any other medical treatment, requires that you rely on the professionalism of the doctors and staff of the clinic you choose. Obviously, each clinic is different. Get now your Fertility Report, which will select several clinics for you out of the pool of clinics that meet our strict quality criteria. Moreover, it will offer you a comparison between the fees and conditions each clinic offers in order for you to make a well informed choice.
We use the term tubal factor infertility when referring to alterations or problems in the Fallopian tubes, the part of the female reproductive system where fertilization takes place.
During ovulation, an egg is released from the ovary and travels to the Fallopian tubes, so that a sperm reaches and fertilizes it. After fertilization, the resulting embryo travels through the tubes toward the uterus, where it will implant and give rise to a new pregnancy.
In order for these steps to take place, tubal patency in both Fallopian tubes, or at least in one of them, is necessary. They have to be functional as well. If both tubes are blocked, we consider that the woman suffers from tubal factor infertility.
Abnormalities related to tubal patency can be caused by infections, endometriosis, salpingitis, tubal malformations, hydrosalpinx, surgery and pelvic inflammatory disease (PID).
Hysterosalpingography (HSG) is a diagnostic test that allows us to evaluate the functionality of the uterine tubes.
If you want to learn more then please visit the following article: Tubal factor infertility.
The cervix the first place that sperm must pass through on their way to the egg. There may be obstructions in the form of tumors or fibroids that hinder fertilization.
On the other hand, the cervical mucus also helps the spermatozoa to move through the uterine interior, providing them with a medium through which to travel.
Some of the causes that cause infertility in women because they prevent the sperm from reaching the fallopian tubes to fertilize the egg are inflammations, infections or pH changes.
If you are interested in this topic, we invite you to read the following article: Female infertility due to cervical abnormalities.
There exist two main causes behind female infertility due to uterine abnormalities: on the one hand, uterine malformations, and on the other hand conditions related to the endometrium.
The endometrium or endometrial lining is the inner layer of the uterus where the implantation and attachment of the embryo take place.
Uterine abnormalities can be congenital, that is, from birth, or appear later in life as a consequence of fibroids, myomas, or cysts.
Also, it should be taken into account that endometriosis is infertility of uterine origin as well. It is a condition caused by the inflammation of the endometrial tissue, which grows outside the uterine cavity. Depending on the severity, it can be more or less perjudicial to a woman's fertility.
Click here if you want to get further information about this subject: Female infertility due to uterine abnormalities.
There are other factors that affect sterility, but they can occur in both sexes, such as the following:
Research advances in the field of human fertility lead day by day to the discovery of new causes of sterility, so that it is possible to outline new treatments and drugs to combat all these problems.
Female infertility can go unnoticed or, conversely, certain signs can make it quite obvious.
For example, in cases of female sterility due to endocrine factors, hormonal alterations usually lead to amenorrhea or menstrual irregularities, signs that some kind of problem exists, and are reasons for a woman to visit a fertility specialist.
Also, a blockage in the Fallopian tubes or the presence of myomas in the uterine cavity can cause the woman to feel pain or at least some sort of discomfort. There are, however, cases in which the patient has no noticeable symptoms, and is therefore totally unaware that there is a fertility issue that needs to be supervised by a duly qualified specialist.
Due to this wide range of signs, females, in general, are recommended to attend every routine gynecological consultation, and not to visit the specialist only in case of pain, discomfort or menstrual alterations.
Contrary to what happens in men, women do not produce eggs de novo but are born with a finite number of eggs. From puberty and until menopause, ovulation of a large part of them will occur and the rest will degenerate on the maturation path to ovulation.
A woman's fertile period ranges from approximately 16 to 30-35 years of age. From this age, and especially from the age of 40, a woman's fertility progressively decreases until the complete depletion of the egg reserve at menopause.
In fact, Dr. Gorka Barrenetxea, a specialist in Gynecology and Obstetrics, tells us that:
The average age of the women who come to our center is 37-38 years old.
In a situation of female infertility, the treatment necessary to achieve pregnancy will depend on its cause. Therefore, specialists recommend that each case be approached individually and that a personalized treatment protocol be developed.
In addition to the origin of the infertility, there are other factors that will influence the choice of the most appropriate treatment, such as the age of the woman and the male factor, mainly.
Once each case has been analyzed and all the necessary diagnostic tests have been performed, the fertility treatments that a woman or couple can use to have a child are as follows:
Each of these treatments should be adapted to each woman according to her specific characteristics and causes of infertility. If you need more detailed information about this, you can continue reading in the following post: Techniques and treatments to combat female infertility.
Answered by Fertility Madrid
Yes, unfortunately the passage of time has a very negative influence. The fertile age is between puberty and menopause. Within this period, the best conditions are usually up to 35 years of age. As a woman's age increases, her ovarian reserve and the quality of her eggs decreases.
In short, the older a woman gets, the lower her fertility not only translates into a lower probability of pregnancy, but also into an increase in the number of miscarriages due to chromosomal abnormalities and complications during pregnancy.
A woman is said to be infertile when she is unable to become pregnant within 1 year of having unprotected sexual intercourse regularly, after ruling out male causes.
There are a great variety of causes of greater or lesser severity. That is why in many cases it may happen that the woman is not aware of her problem until the necessary sterility tests are performed, since in many cases she does not show any symptoms.
There are 2 types of sterility:
To know the state of our ovarian reserve, it is best to perform an ultrasound to assess the antral follicle count, and a hormone analysis to determine the levels of FSH and antimullerian hormone.
And finally, it is necessary to know that the period of greatest fertility in women is from 16 to 30-35 years of age approximately, with fertility being clearly affected from the age of 40 onwards.
Yes, it is possible. However, there are differing opinions when reviewing the literature regarding ovarian-hormonal function after oophorectomy.
Some studies indicate a lesser effect on female fertility when the procedure is performed at a younger age. Other studies point out that patients with only one ovary respond less to ovarian stimulation with lower oocyte collection and have a higher follicle stimulating hormone (FSH), an indicator of a low response to stimulation in in-vitro fertilization (IVF) protocols.
It will depend on each woman and her ovarian reserve. A woman can be a mother naturally until she reaches the menopausal stage. However, as she approaches this stage, reproductive capacity decreases.
In any case and in general terms, we can say that from the age of 35 onwards, female fertility gradually decreases and it does so more markedly from the age of 40 onwards.
In order to know the fertility status of a woman, there are a series of medical tests that help to measure the woman's ovarian reserve and to study her reproductive capacity.
Among them are cytology, physical examination of the female reproductive system, the analysis of hormones such as FSH or AMH, etc.
Depending on the cause of infertility, one solution or another will be provided to achieve pregnancy. Assisted reproduction offers a wide range of techniques and treatments so that women with infertility can become pregnant and fulfill their desire to become mothers.
The most common techniques are artificial insemination, in vitro fertilization (conventional or ICSI), PGD (preimplantation genetic diagnosis), egg and sperm donation, etc.
Sterility or infertility in women arises from some alteration in the proper functioning of the entire reproductive system for all the reasons we have already discussed. First of all, if you want to know what a woman's fertility consists of and what her ideal development should be like, we recommend you to visit the following post: Fertility in women.
A woman's menstrual cycle is key to achieving pregnancy. To get all the information about what happens in each of its stages, you can read the following article: What is the menstrual cycle?
We make a great effort to provide you with the highest quality information.
🙏 Please share this article if you liked it. 💜💜 You help us continue!
Al-Badawi IA, Fluker MR, Bebbington MW. Diagnostic laparoscopy in infertile women with normal hysterosalpingograms. J Reprod Med 1999; 44:953-7.
Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimüllerian Hormone Levels Are Strongly Associated With Live-Birth Rates After Assisted Reproduction. J Clin Endocrinol Metab. March 2013, 98(3):1107–1114 (View)
Carvajal R, Alba J, Cortínez A, Carvajal A, Miranda C, Romero C, Vantman D. Niveles de hormona antimüllerina y factor neurotrófico derivado del cerebro como predictores de función ovárica. Rev Hosp Clín Univ Chile 2012; 23: 159-67 (View)
Celik H, Bıldırcın D, Güven D, Cetinkaya MB, Alper T, Batuoğlu S. Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels Anti-Müllerian hormone in poor responders in assisted reproductive treatment. J Assist Reprod Genet, 2012; 29:797–802 (View)
Guzman L, Ortega-Hrepich C, Polyzos NP, Anckaert E, Verheyen G, Coucke W, Devroey P, Tournaye H, Smitz J, De Vos M. A prediction model to select PCOS patients suitable for IVM treatment based on anti-Müllerian hormone and antral follicle count. Human Reproduction, 2013, 28 (5): 1261–1266 (View)
Pellerito JS, McCarthy SM, Doyle MB, Glickman MG, DeCherney AH. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography. Radiology 1992; 183:795-800 (View)
Prof. Mary Wingfield (2017). The Fertility Handbook: Everything You Need to Know to Maximise Your Chance of Pregnancy, Gill & Macmillan Ltd, May 29, 2017
Romero Guadix B, Martínez Navarro L, Arribas Mir L. Esterilidad: manejo desde la consulta del médico de familia. AMF. 2002; 8 (6): 304-311 (View)
Royal College of Obstetricians and Gynaecologists. Fertility: assessment and treatment for people with fertility problems. NICE Clinical Guideline. February 2013.